We are excited to bring you a series of 2 CPD accredited webinars along with 4 expert videos designed to help Healthcare Professionals (HCPs) provide better care to older adults living with diabetes. Please see the full details below for each of the training webinar.
Webinar #1 – Diabetes Management in an Ageing Population
Mon 12 Oct - 7pm to 8pm
The risk of type 2 diabetes increases with age. Older adults with diabetes are a diverse group of patients ranging from generally healthy and active to those with severe frailty. Patients with diabetes and frailty will normally require an adjustment of the treatment plan to mitigate the risks of intense treatment. This webinar will review the impact of frailty on diabetes and its management.
Speakers: Su Down & Dr David Strain
- Discuss the demographics of type 2 diabetes in an aging population
- Review the relationship between diabetes, frailty and aging
- Examine the pathophysiology of diabetes, hypoglycaemia and dementia
Webinar #2 – Assessing Frailty in your Practice
Mon 26 Oct - 7pm to 8pm
Novo Nordisk product information will be discussed. Prescribing information and adverse event reporting information will be available at the meeting.
Frailty has a major impact on the management of patients with type 2 diabetes. These patients have different management strategies and HbA1c targets. This webinar will review the healthcare professional assessment of frailty in the older adult, setting HbA1c targets and antihyperglycaemic therapy selection in this patient population.
Speakers: Su Down & Dr David Strain
- Assess frailty in patients with diabetes in primary care
- Review the different frailty assessment tools and protocols
- Determine appropriate HbA1c targets for older adults with diabetes and frailty
- Individualise type 2 diabetes in an older adult with type 2 diabetes
Su Down is a Nurse Consultant in Diabetes and is the Clinical Lead for the Intermediate Diabetes community service in Somerset. Nationally she is the Editor in Chief of the Journal of Diabetes Nursing and joint Vice Chair of the PCDS (Primary Care Diabetes Society). Former national roles have included being a TREND associate, board member of FIT (Forum for Injection Technique) and committee member of the Health Care Professionals Council of Diabetes UK.
Dr David Strain is a Senior Clinical Lecturer at the University of Exeter Medical School, with an expertise in microvascular structure and function. Clinically, he runs a community diabetes service for the older adult, and works as an in-patient stroke consultant. Prior to this, Dr Strain studied at Liverpool University before completing his Doctorate in Medicine on ‘The ethnic difference in the effects of insulin resistance on the vasculature’ at the International Centre for Cardiovascular Health, Imperial College, London.
Video #1 - Application of frailty assessment
Not every older adult with diabetes should be managed similarly. This video will review the management of two patients who are the same age but with vastly different levels of frailty. It will also review frailty assessment and HbA1c target setting for these patients.
- Review frailty assessment in primary care
- Discuss the pros and cons of the different frailty assessment tools
- Determine appropriate HbA1c targets based on the level of frailty
Video # 2 – Hypoglycaemia in the older adult
Hypoglycaemia can have a major impact on older adults. This video discusses the identification and management of hypoglycaemia. It will also review the impact of hypoglycaemia on older adults and strategies to mitigate its risk.
- Define hypoglycaemia and its clinical presentation in older adults
- Review the impact of hypoglycaemia on the frail older adult
- Develop strategies to mitigate hypoglycaemia in older adults
Video # 3 – Antihyperglycaemic agent selection in the older adult
There are a large variety of antihyperglycaemic agents to manage patients with type 2 diabetes. The benefits and risks of these agents can be different in an older adult with frailty compared to a younger individual. This video will review the key considerations when selecting antihyperglycemic therapy in your older adult patients.
- Review the key considerations for antihyperglycaemic therapy selection in older adults
- Discuss the benefits and risks of using antihyperglycaemic therapy classes in older adults
- Individualize therapy in an older adult with type 2 diabetes
Video # 4 – Deprescribing diabetes therapy
As frailty increases in an older adult, the benefits from certain therapies increase while risks increase. This video will discuss how healthcare professionals should address clinical inertia in patients requiring treatment intensification but also reduce the pill burden in those older adults who would benefit from a decrease in pharmacotherapy.
- Individualise therapy in two patients with type 2 diabetes with and without frailty
- Minimise clinical inertia in the healthy older adult require treatment intensification
- Reduce the pill burden in older adults with frailty
Date of prep August 2020 - Job Code uk20tsm00127